Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $2.68 M | -89.68% |
2023 | $26 M | -3.87% |
2022 | $27.05 M | -24.36% |
2021 | $35.76 M | -61.48% |
2020 | $92.85 M | 217.25% |
2019 | $29.26 M | -60.68% |
2018 | $74.43 M | 66.59% |
2017 | $44.68 M | -18.44% |
2016 | $54.78 M | -33.54% |
2015 | $82.43 M | 51.23% |
2014 | $54.5 M | 57.97% |
2013 | $34.5 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Sanofi SNY | $29.8 M | $76.77 M | ๐ซ๐ท France |
Ultragenyx RARE | $0.22 M | $14.62 M | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $0.22 M | $1.7 M | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | $2.29 M | $8.5 M | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $1 M | $4.85 M | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $0.28 M | $3.79 M | ๐บ๐ธ USA |